scout
|Videos|June 20, 2017

Phase II Results for Pembrolizumab Monotherapy in Metastatic TNBC

Sylvia Adams, MD, associate professor, Department of Medicine, NYU Langone Medical Center, discusses phase II results from cohort A of the KEYNOTE-086 trial, which explored pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME